Image

Global Pharyngoconjunctival Fever Market – Industry Trends and Forecast to 2031

Pharmaceutical

Image

Global Pharyngoconjunctival Fever Market – Industry Trends and Forecast to 2031

  • Pharmaceutical
  • Upcoming Report
  • Apr 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Pharyngoconjunctival Fever Market – Industry Trends and Forecast to 2031

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2023–2031
Diagram Market Size (Base Year) USD 9.52 USD Billion
Diagram Market Size (Forecast Year) USD 15.99 USD Billion
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Pharyngoconjunctival Fever Market, By Causes (Fever, Pharyngitis, Acute Follicular Conjunctivitis, Regional Lymphoid Hyperplasia with Tender, and Enlarged Preauricular Adenopathy), Treatment (Cold Compresses and Others), End-Users (Hospitals, Homecare, Specialty Clinics, and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy)  – Industry Trends and Forecast to 2031.

Pharyngoconjunctival Fever Market

Pharyngoconjunctival Fever Market Analysis and Size

The National Institute of Infectious Diseases in Japan has reported a decade-high number of cases of pharyngoconjunctival fever, also known as swimming pool fever. This summer illness, common among children and often transmitted in swimming pools, has prompted alerts in Osaka and Fukuoka prefectures due to increased cases.  The disease is mainly transmitted through droplets and contact, including shared towels. Monitoring of pediatric hospitals revealed an average of 1.45 patients per institution, exceeding previous decade highs. Fukuoka and Osaka prefectures have seen averages above the alert threshold of 3, with 4.65 and 4.09 patients respectively. The outbreak is particularly pronounced in the Kansai region, with figures of 2.95, 2.88, and 2.19 in Kyoto, Nara, and Hyogo prefectures respectively. Authorities are emphasizing hygiene practices and caution, as the virus can persist in urine and feces for up to a month after symptoms resolve.

The global pharyngoconjunctival fever market size was valued at USD 9.52 billion in 2023 and is projected to reach USD 15.99 billion by 2031, with a CAGR of 6.70% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation       

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016 - 2021)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Causes (Fever, Pharyngitis, Acute Follicular Conjunctivitis, Regional Lymphoid Hyperplasia with Tender, and Enlarged Preauricular Adenopathy), Treatment (Cold Compresses and Others), End-Users (Hospitals, Homecare, Specialty Clinics, and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy) 

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America

Market Players Covered

Bausch Health Companies Inc. (Canada.), Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Astellas Pharma Inc. (Japan), Bayer AG (Germany), Novartis AG (Switzerland), AstraZeneca (U.K.), Lilly (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), GSK plc (U.K.), Hikma Pharmaceuticals PLC (U.K.), Cipla Inc. (India), Lupin (India), Boehringer Ingelheim International GmbH. (Germany), Ipsen Pharma (France), ABIOGEN PHARMA SpA (Italy), Zimmer Biomet (U.S.), Ampio Pharmaceuticals Inc., eneron Pharmaceuticals Inc (U.S.), Astellas Pharma Inc. (Japan)., DAIICHI SANKYO COMPANY, LIMITED (Japan), and Endo International Inc. (Ireland)

Market Opportunities

  • Increasing Healthcare Expenditure      
  • Growing Demand for Symptomatic Relief    

Market Definition

Pharyngoconjunctival fever is a viral infection characterized by inflammation of the pharynx (the back of the throat) and conjunctiva (the mucous membrane that covers the front of the eye and lines the inside of the eyelids). It is typically caused by adenoviruses and is characterized by symptoms such as sore throat, redness and irritation of the eyes, fever, and sometimes swollen lymph nodes.    

Pharyngoconjunctival Fever Market Dynamics

Drivers

  • Increasing Prevalence of Adenovirus Infections          

 Adenoviruses are a common cause of respiratory and gastrointestinal infections, and they can also lead to PCF. The increasing incidence of adenovirus infections is paralleled by a rise in PCF cases, fueling the demand for treatments and management options. This growing prevalence is particularly notable in settings where close contact among individuals is common, such as schools, military barracks, and daycare centers. The increasing recognition of adenoviruses as a significant pathogen, along with the development of more sensitive diagnostic tests, is also contributing to the rise in reported cases of PCF. This is expected to continue to drive market growth for PCF treatments.

  • Rising Awareness and Diagnosis

There is a growing awareness among healthcare professionals about PCF, leading to improved diagnosis and treatment. Healthcare providers are becoming more adept at recognizing the symptoms of PCF and distinguishing it from other similar conditions. This trend towards accurate diagnosis and appropriate treatment is expected to drive market growth as more cases are identified and managed effectively. The increasing awareness about PCF is also leading to better patient outcomes and reduced complications, further driving the demand for PCF treatments.       

Opportunities

  • Increasing Healthcare Expenditure      

As more resources are allocated to healthcare, there is a greater focus on managing and treating common viral infections such as PCF. This includes investment in healthcare infrastructure, diagnostic tools, and treatments. The growing healthcare expenditure is expected to drive market growth for PCF treatments as more people have access to healthcare services and are able to seek treatment for their symptoms. The increasing healthcare expenditure, particularly in developing regions, presents a significant market opportunity for PCF treatments.          

  • Growing Demand for Symptomatic Relief     

PCF is characterized by symptoms such as sore throat and fever, which can be uncomfortable and debilitating. As a result, there is a strong demand for over-the-counter medications and remedies that can provide relief from these symptoms. This includes pain relievers, fever reducers, and throat lozenges, among other products. The market for these products is expected to grow as the incidence of PCF increases, and more people seek relief from their symptoms. The demand for symptomatic relief for Pharyngoconjunctival fever (PCF) presents a significant market opportunity.

Restraints/Challenges

  • Seasonal Variations in Incidence        

Adenovirus infections tend to be more common in certain seasons, such as late winter and early spring, leading to fluctuations in demand for PCF treatments. The seasonal fluctuations pose challenges for healthcare providers and pharmaceutical companies in forecasting and preparing for the demand for PCF treatments. In addition, the seasonal nature of adenovirus infections highlights the importance of timely and targeted interventions to manage outbreaks and reduce the burden of PCF during peak seasons. Seasonal variations in the incidence of adenovirus infections, and consequently PCF, can pose challenges for the market.       

  • Lack of Specific Treatment         

PCF is caused by adenoviruses, which are not susceptible to antibiotics, so treatment focuses on managing symptoms. This limitation in treatment options can hinder market growth as patients and healthcare providers seek more targeted and effective therapies. The absence of a specific treatment also underscores the importance of preventive measures, such as hygiene practices and vaccination against adenoviruses, which could reduce the incidence of PCF and its impact on affected individuals. The lack of specific treatments for Pharyngoconjunctival fever (PCF) is a major restraint for the market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Pharyngoconjunctival Fever Market Scope

The market is segmented on the basis of causes, treatment, distribution channel, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Causes

  • Fever
  • Pharyngitis
  • Acute Follicular Conjunctivitis
  • Regional Lymphoid Hyperplasia with Tender
  • Enlarged Preauricular Adenopathy

Treatment

  • Cold Compresses
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The haryngoconjunctival fever market size will be worth USD 15.99 billion by 2031.
The growth rate of the haryngoconjunctival fever market is 6.70%.
Increasing Prevalence of Adenovirus Infections & Rising Awareness and Diagnosis are the growth drivers of the haryngoconjunctival fever market.
Causes, treatment, distribution channel, and end-use are the factors on which the haryngoconjunctival fever market research is based.
Major companies in the haryngoconjunctival fever market are Bausch Health Companies Inc. (Canada.), Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Astellas Pharma Inc. (Japan), Bayer AG (Germany), Novartis AG (Switzerland), AstraZeneca (U.K.), Lilly (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), GSK plc (U.K.), Hikma Pharmaceuticals PLC (U.K.), Cipla Inc. (India), Lupin (India), Boehringer Ingelheim International GmbH. (Germany), Ipsen Pharma (France), ABIOGEN PHARMA SpA (Italy), Zimmer Biomet (U.S.), Ampio Pharmaceuticals Inc., eneron Pharmaceuticals Inc (U.S.), Astellas Pharma Inc. (Japan)., DAIICHI SANKYO COMPANY, LIMITED (Japan), and Endo International Inc. (Ireland).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials